Supply of pharmaceuticals, para-pharmaceuticals, medical devices, and products subject to exclusive rights for the year 2026 - Determination No. 6 of 17/02/2026

The tender involves the supply of pharmaceuticals, para-pharmaceuticals, medical devices, and products subject to exclusive rights for the year 2026, issued by the Contracting Authority AZIENDA GESTIONE EDIFICI COMUNALI A.G.E.C. The estimated value of the contract is EUR 145,000.00, and it falls under the category of supplies, specifically classified under the CPV code for pharmaceutical products. The procurement process is a negotiated procedure without prior publication of a tender notice. The location for the execution of this contract is Verona, Italy. The awarded contract has been granted to GlaxoSmithKline S.p.A., with the award value matching the estimated contract value at EUR 145,000.00. Interested parties can access the tender documents through the provided link to the transparency portal. This tender is significant for ensuring the availability of essential medical supplies and pharmaceuticals in the region, thereby contributing to public health needs.

This is a supplies contract in the general supplies sector. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 145,000.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.